These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32883971)

  • 1. Association of TDP-43 proteinopathy, cerebral amyloid angiopathy, and Lewy bodies with cognitive impairment in individuals with or without Alzheimer's disease neuropathology.
    Thomas DX; Bajaj S; McRae-McKee K; Hadjichrysanthou C; Anderson RM; Collinge J
    Sci Rep; 2020 Sep; 10(1):14579. PubMed ID: 32883971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated.
    Robinson JL; Lee EB; Xie SX; Rennert L; Suh E; Bredenberg C; Caswell C; Van Deerlin VM; Yan N; Yousef A; Hurtig HI; Siderowf A; Grossman M; McMillan CT; Miller B; Duda JE; Irwin DJ; Wolk D; Elman L; McCluskey L; Chen-Plotkin A; Weintraub D; Arnold SE; Brettschneider J; Lee VM; Trojanowski JQ
    Brain; 2018 Jul; 141(7):2181-2193. PubMed ID: 29878075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinico-Neuropathological Findings in the Oldest Old from the Georgia Centenarian Study.
    Tanprasertsuk J; Johnson EJ; Johnson MA; Poon LW; Nelson PT; Davey A; Martin P; Barbey AK; Barger K; Wang XD; Scott TM
    J Alzheimers Dis; 2019; 70(1):35-49. PubMed ID: 31177211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.
    James BD; Wilson RS; Boyle PA; Trojanowski JQ; Bennett DA; Schneider JA
    Brain; 2016 Nov; 139(11):2983-2993. PubMed ID: 27694152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development and convergence of co-pathologies in Alzheimer's disease.
    Robinson JL; Richardson H; Xie SX; Suh E; Van Deerlin VM; Alfaro B; Loh N; Porras-Paniagua M; Nirschl JJ; Wolk D; Lee VM; Lee EB; Trojanowski JQ
    Brain; 2021 Apr; 144(3):953-962. PubMed ID: 33449993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE ε4 haplotype status: a community-based cohort study.
    Yang HS; Yu L; White CC; Chibnik LB; Chhatwal JP; Sperling RA; Bennett DA; Schneider JA; De Jager PL
    Lancet Neurol; 2018 Sep; 17(9):773-781. PubMed ID: 30093249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of Lewy bodies with limbic-predominant age-related TDP-43 encephalopathy neuropathologic changes and their role in cognition and Alzheimer's dementia in older persons.
    Agrawal S; Yu L; Nag S; Arfanakis K; Barnes LL; Bennett DA; Schneider JA
    Acta Neuropathol Commun; 2021 Sep; 9(1):156. PubMed ID: 34563269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lewy body pathology modifies risk factors for cerebral amyloid angiopathy when comorbid with Alzheimer's disease pathology.
    Pillai JA; Bena J; Tousi B; Rothenberg K; Keene CD; Leverenz JB
    Alzheimers Dement; 2024 Apr; 20(4):2564-2574. PubMed ID: 38353367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.
    Yu L; Petyuk VA; Tasaki S; Boyle PA; Gaiteri C; Schneider JA; De Jager PL; Bennett DA
    JAMA Neurol; 2019 Jul; 76(7):818-826. PubMed ID: 31009033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dichotomous scoring of TDP-43 proteinopathy from specific brain regions in 27 academic research centers: associations with Alzheimer's disease and cerebrovascular disease pathologies.
    Katsumata Y; Fardo DW; Kukull WA; Nelson PT
    Acta Neuropathol Commun; 2018 Dec; 6(1):142. PubMed ID: 30567576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.
    Irwin DJ; Grossman M; Weintraub D; Hurtig HI; Duda JE; Xie SX; Lee EB; Van Deerlin VM; Lopez OL; Kofler JK; Nelson PT; Jicha GA; Woltjer R; Quinn JF; Kaye J; Leverenz JB; Tsuang D; Longfellow K; Yearout D; Kukull W; Keene CD; Montine TJ; Zabetian CP; Trojanowski JQ
    Lancet Neurol; 2017 Jan; 16(1):55-65. PubMed ID: 27979356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence, correlation, and co-occurrence of neuropathology in old age: harmonisation of 12 measures across six community-based autopsy studies of dementia.
    Nichols E; Merrick R; Hay SI; Himali D; Himali JJ; Hunter S; Keage HAD; Latimer CS; Scott MR; Steinmetz JD; Walker JM; Wharton SB; Wiedner CD; Crane PK; Keene CD; Launer LJ; Matthews FE; Schneider J; Seshadri S; White L; Brayne C; Vos T
    Lancet Healthy Longev; 2023 Mar; 4(3):e115-e125. PubMed ID: 36870337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limbic-Predominant Age-Related TDP-43 Encephalopathy: Medical and Pathologic Factors Associated With Comorbid Hippocampal Sclerosis.
    Gauthreaux KM; Teylan MA; Katsumata Y; Mock C; Culhane JE; Chen YC; Chan KCG; Fardo DW; Dugan AJ; Cykowski MD; Jicha GA; Kukull WA; Nelson PT
    Neurology; 2022 Apr; 98(14):e1422-e1433. PubMed ID: 35121671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer diagnosis is associated with a lower burden of dementia and less Alzheimer's-type neuropathology.
    Karanth SD; Katsumata Y; Nelson PT; Fardo DW; McDowell JK; Schmitt FA; Kryscio RJ; Browning SR; Braithwaite D; Arnold SM; Abner EL
    Brain; 2022 Jul; 145(7):2518-2527. PubMed ID: 35094057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies.
    Schneider JA; Arvanitakis Z; Yu L; Boyle PA; Leurgans SE; Bennett DA
    Brain; 2012 Oct; 135(Pt 10):3005-14. PubMed ID: 23065790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. To what degree is late life cognitive decline driven by age-related neuropathologies?
    Boyle PA; Wang T; Yu L; Wilson RS; Dawe R; Arfanakis K; Schneider JA; Bennett DA
    Brain; 2021 Aug; 144(7):2166-2175. PubMed ID: 33742668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier - phenotypic variability in autosomal dominant Alzheimer's disease.
    Lloyd GM; Trejo-Lopez JA; Xia Y; McFarland KN; Lincoln SJ; Ertekin-Taner N; Giasson BI; Yachnis AT; Prokop S
    Acta Neuropathol Commun; 2020 Mar; 8(1):31. PubMed ID: 32164763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson's disease dementia.
    Hansen D; Ling H; Lashley T; Foley JA; Strand C; Eid TM; Holton JL; Warner TT
    Neuropathol Appl Neurobiol; 2021 Feb; 47(1):143-156. PubMed ID: 32720329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between Comorbid TDP-43, Lewy Body Pathology, and Neuropsychiatric Symptoms in Alzheimer's Disease.
    Bayram E; Shan G; Cummings JL
    J Alzheimers Dis; 2019; 69(4):953-961. PubMed ID: 31127776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden.
    Banerjee G; Kim HJ; Fox Z; Jäger HR; Wilson D; Charidimou A; Na HK; Na DL; Seo SW; Werring DJ
    Brain; 2017 Apr; 140(4):1107-1116. PubMed ID: 28335021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.